Send Inquiry

Request To Call Back

Geftinat Tablets IP

Name: Geftinat Tablets IP
Brand: DHRITEE IMPEX

Get a Price/Quote

MOQ : 10 Packs

Geftinat Tablets IP Specification

Dosage Form
Tablets

Indication
Non-Small Cell Lung Cancer (NSCLC)

Salt Composition
Gefitinib 250 mg

Feature
Other

Ingredients
Other

Application
Other

Physical Color/Texture
Film-coated tablets; white to off-white

Storage Instructions
Dry Place

Shelf Life
24 months

Packaging Type
Box of 30 tablets

Route of Administration
Oral

Excipients
Lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium lauryl sulphate, magnesium stearate, hypromellose, macrogol, titanium dioxide, iron oxide yellow

Warning
To be sold by retail on the prescription of an Oncologist only

ATC Code
L01EB01

Prescription Requirement
Prescription only

Strength
250 mg per tablet

International Trade Name
Iressa (Reference)

Geftinat Tablets IP Trade Information

Minimum Order Quantity
10 Packs

Payment Terms
Western Union

Supply Ability
100 Packs Per Day

Delivery Time
7 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Geftinat Tablets IP

Company Name: Dhritee Impex

Service Description for Geftinate 250 MG:

Dhritee Impex is pleased to introduce Geftinate 250 MG, a cutting-edge pharmaceutical product designed to offer precision in the treatment of certain types of cancer, specifically targeting and inhibiting the growth of cancer cells.

Key Features:

Targeted Cancer Treatment: Geftinate 250 MG is a powerful medication containing gefitinib, which acts as a tyrosine kinase inhibitor. This targeted therapy is designed to specifically inhibit the activity of the epidermal growth factor receptor (EGFR), contributing to the suppression of cancer cell growth.
Optimized Dosage Strength: Our commitment to effective cancer management is reflected in the optimized dosage strength of Geftinate 250 MG. This ensures a balance between therapeutic efficacy and safety, allowing for precise cancer treatment.
Personalized Cancer Care: Geftinate 250 MG exemplifies the move towards personalized cancer care. By targeting specific molecular pathways, this medication aims to tailor treatment to the unique characteristics of the patient's cancer, offering a more personalized and effective approach.
Quality Assurance: At Dhritee Impex, quality is non-negotiable. Geftinate 250 MG undergoes rigorous testing and adheres to stringent quality control measures, ensuring that each tablet meets the highest standards of pharmaceutical excellence.
Comprehensive Cancer Support: We understand the challenges associated with cancer treatment. Dhritee Impex is committed to providing comprehensive support to individuals using Geftinate 250 MG, with a focus on addressing inquiries, providing information, and ensuring a positive treatment experience.
Patient Advocacy: Dhritee Impex advocates for patients' well-being by providing resources, educational materials, and a dedicated customer support team to assist individuals throughout their cancer treatment journey.

Why Choose Geftinate 250 MG from Dhritee Impex:

Expertise in Oncology: Dhritee Impex brings a wealth of expertise to the field of oncology, ensuring that Geftinate 250 MG is a reliable and effective solution for cancer treatment.
Precision Medicine: Geftinate 250 MG represents the forefront of precision medicine in cancer care, targeting specific molecular mechanisms to enhance treatment efficacy.
Commitment to Patient Welfare: Dhritee Impex is committed to the welfare of patients undergoing cancer treatment. Geftinate 250 MG reflects this commitment through its targeted therapy and comprehensive support services.

Choose Dhritee Impex for Geftinate 250 MG, and let us be your partner in the journey towards effective and personalized cancer treatment. Your health and comfort are our utmost priorities.

Targeted Cancer Therapy

Geftinat Tablets IP are specifically indicated for non-small cell lung cancer (NSCLC), targeting tumors that express certain gene mutations. As a targeted therapy, gefitinib works by blocking the signals that help cancer cells grow and divide. This focused approach maximizes treatment effectiveness while reducing non-target effects.

Administration and Dosage

These tablets are intended for oral use, making them convenient for patients to take at home. The recommended dosage is one 250 mg tablet daily, as prescribed by your oncologist. It is essential to follow your doctor's instructions and not to alter the dosage without medical advice.

FAQ's of Geftinat Tablets IP:

Q: How should Geftinat Tablets IP be taken for optimal results?

A: Geftinat Tablets IP must be taken orally as prescribed by your oncologist, typically one tablet (250 mg) once daily with or without food. It is important to swallow the tablet whole and to maintain a consistent routine for best efficacy.

Q: What is Geftinat (Gefitinib 250mg) used for?

A: Geftinat is primarily used to treat non-small cell lung cancer (NSCLC), especially in patients whose tumors have specific genetic mutations that make them sensitive to gefitinib treatment.

Q: When is a prescription required for Geftinat Tablets?

A: A valid prescription from a licensed oncologist is mandatory to purchase Geftinat Tablets, as it is strictly regulated to ensure safe and appropriate usage in cancer treatment.

Q: Where should Geftinat Tablets be stored to maintain their quality?

A: Store Geftinat Tablets in a dry place at room temperature, away from moisture and direct sunlight, to preserve their stability and ensure their effectiveness throughout the 24-month shelf life.

Q: What is the process for obtaining Geftinat Tablets?

A: Geftinat Tablets can be obtained from authorized dealers, exporters, producers, suppliers, or traders in India, but only upon presentation of a prescription from an oncologist, in line with national regulations.

Q: What are the potential benefits of using Geftinat in cancer therapy?

A: Geftinat provides targeted therapy by inhibiting specific pathways involved in cancer cell growth, which can result in better treatment outcomes and fewer adverse effects compared to conventional chemotherapy.

Tell us about your requirement